-
Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange
[ad_1] NEW YORK, NY – (NewMediaWire) – January 15, 2021 – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a…
Read More » -
Neovasc Responds To FDA Not-Approvable Letter Regarding Neovasc Reducer
[ad_1] VANCOUVER and MINNEAPOLIS – (NewMediaWire) – January 15, 2021 – Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced…
Read More » -
BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
[ad_1] Anaheim, CA – (NewMediaWire) – January 15, 2021 – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of…
Read More » -
News
Tauriga Sciences Inc. Completes Payment for the Entirety of its Initial Production Run of its Caffeine Infused Version of Tauri-Gum
[ad_1] This Caffeine Version of Tauri-Gum™ is the 7th SKU of this Fast-Growing Product Line NEW YORK, NY – (NewMediaWire)…
Read More » -
Sentaida Tire Company Ltd. Announces Acquisition of GivBux Global Partners, Inc. and Change of Name to GivBux, Inc.
[ad_1] Newport Beach, CA – (NewMediaWire) – January 14, 2021 – Sentaida Tire Company, Ltd., (OTC Markets: SDTC) announced today…
Read More »